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Background: CD133+/CD34-/KDR+ cells may represent less mature progenitors than CD34+/KDR+ cells. In patients with coronary artery disease 
(CAD), a large fraction of progenitors carry the osteoblastic marker osteocalcin, which may mediate vascular calcification and abnormal repair. We 
evaluated the expression and prognostic role of osteocalcin+ CD133+CD34-/KDR+ cells in patients with cardiovascular risk factors (cvRF), a history 
of stable CAD (stenting or CABG without myocardial infarction (MI)), and a history of unstable CAD (MI).
Methods: Blood samples from 282 patients (age 58±16yrs) were analyzed. All patients had CAD or at least one RF. For analysis of CD133, CD34, 
KDR and osteocalcin, flow cytometry of peripheral blood mononuclear cells was performed.
Results: Circulating osteocalcin+ CD133+/CD34-/KDR+ cells (counts per 100000 events) were 15 [IQR 4/41] in patients with cvRF, 26 [1,136] and 
246 [105/308] in those with a history of stable and unstable CAD, respectively; p<0.001, Figure 1a. The association remained highly significant after 
adjusting for RF and age. Event-free survival was lower in patients with higher levels of these cells (median follow-up 519 days, p=0.036, Figure 1b).
Conclusion: This study demonstrates that the circulating number of osteocalcin+ CD133+/CD34-/KDR+ cells is associated with the severity of 
CAD and its prognosis. These cells may therefore play an important role in mediating abnormal vascular repair and predicting CV events.
